When does West Pharmaceutical Services, Inc. (WST) report earnings? On Oct 29, 2026, before the open
Of its last 12 earnings announcements: 12 before the open. Each one comes from the 8-K with item 2.02 that West Pharmaceutical Services filed with the SEC, paired with the 10-Q or 10-K for that same quarter: 65 quarters since Aug 3, 2010, and every row links to its filing.
Next announced date: Oct 29, 2026, before the open. It comes from the company through the public Nasdaq calendar, not from the SEC: it is a scheduled date and companies do move it. Everything else on this page already happened, with its filing attached.
The last 20 quarters, one by one
"Lead": trading sessions between the announcement and the full quarterly report to the SEC (10-Q, or 10-K at fiscal year end). For West Pharmaceutical Services, a median of 0 sessions over the last 12 quarters, i.e. the same market day.
| Announcement | Day | Time (NY) | Session | Quarter ended | SEC report | Lead | Filing |
|---|---|---|---|---|---|---|---|
| Jul 23, 2026 | Thursday | 07:14 | before the open | Jun 30, 2026 | 10-Q · Jul 23, 2026 | 0 sessions | 8-K |
| Apr 23, 2026 | Thursday | 07:11 | before the open | Mar 31, 2026 | 10-Q · Apr 23, 2026 | 0 sessions | 8-K |
| Feb 12, 2026 | Thursday | 07:21 | before the open | Dec 31, 2025 | 10-K · Feb 17, 2026 | 2 sessions | 8-K |
| Oct 23, 2025 | Thursday | 07:15 | before the open | Sep 30, 2025 | 10-Q · Oct 23, 2025 | 0 sessions | 8-K |
| Jul 24, 2025 | Thursday | 07:17 | before the open | Jun 30, 2025 | 10-Q · Jul 24, 2025 | 0 sessions | 8-K |
| Apr 24, 2025 | Thursday | 07:47 | before the open | Mar 31, 2025 | 10-Q · Apr 24, 2025 | 0 sessions | 8-K |
| Feb 13, 2025 | Thursday | 08:00 | before the open | Dec 31, 2024 | 10-K · Feb 18, 2025 | 2 sessions | 8-K |
| Oct 24, 2024 | Thursday | 07:50 | before the open | Sep 30, 2024 | 10-Q · Oct 24, 2024 | 0 sessions | 8-K |
| Jul 25, 2024 | Thursday | 08:05 | before the open | Jun 30, 2024 | 10-Q · Jul 25, 2024 | 0 sessions | 8-K |
| Apr 25, 2024 | Thursday | 07:42 | before the open | Mar 31, 2024 | 10-Q · Apr 25, 2024 | 0 sessions | 8-K |
| Feb 15, 2024 | Thursday | 07:51 | before the open | Dec 31, 2023 | 10-K · Feb 20, 2024 | 2 sessions | 8-K |
| Oct 26, 2023 | Thursday | 07:41 | before the open | Sep 30, 2023 | 10-Q · Oct 26, 2023 | 0 sessions | 8-K |
| Jul 27, 2023 | Thursday | 07:46 | before the open | Jun 30, 2023 | 10-Q · Jul 27, 2023 | 0 sessions | 8-K |
| Apr 27, 2023 | Thursday | 08:04 | before the open | Mar 31, 2023 | 10-Q · Apr 27, 2023 | 0 sessions | 8-K |
| Feb 15, 2023 | Wednesday | no time on the filing | Dec 31, 2022 | 10-K · Feb 21, 2023 | 3 sessions | 8-K | |
| Oct 27, 2022 | Thursday | 07:50 | before the open | Sep 30, 2022 | 10-Q · Oct 27, 2022 | 0 sessions | 8-K |
| Jul 28, 2022 | Thursday | 07:37 | before the open | Jun 30, 2022 | 10-Q · Jul 28, 2022 | 0 sessions | 8-K |
| Apr 28, 2022 | Thursday | 07:52 | before the open | Mar 31, 2022 | 10-Q · Apr 28, 2022 | 0 sessions | 8-K |
| Feb 17, 2022 | Thursday | 07:51 | before the open | Dec 31, 2021 | 10-K · Feb 22, 2022 | 2 sessions | 8-K |
| Oct 28, 2021 | Thursday | 08:17 | before the open | Sep 30, 2021 | 10-Q · Oct 28, 2021 | 0 sessions | 8-K |
The table shows the 20 most recent quarters. All 65 are in the CSV, with the same columns and one row per quarter.
Download all 65 WST quarters as CSV → Free, no account.
How West Pharmaceutical Services shares moved on their latest earnings
Over the 8 announcements with prices in this table, WST rose 4 times and fell 4 times; the median move, ignoring sign, was 11.9%, against 0.8% for SPY over the same windows. The largest, −38.2%, came with the results of Feb 13, 2025. Reported EPS beat the consensus estimate in 5 of the 5 quarters with an estimate.
| Announcement | Session | Window, close to close | WST | SPY | EPS actual / expected |
|---|---|---|---|---|---|
| Jul 23, 2026 | before the open | Jul 22, 2026 → Jul 23, 2026 | −0.8% | −1.2% | 2.37 / 2.08 (+13.9%) |
| Apr 23, 2026 | before the open | Apr 22, 2026 → Apr 23, 2026 | +12.9% | −0.4% | 2.13 / 1.68 (+27.1%) |
| Feb 12, 2026 | before the open | Feb 11, 2026 → Feb 12, 2026 | −1% | −1.5% | 2.04 / 1.83 (+11.5%) |
| Oct 23, 2025 | before the open | Oct 22, 2025 → Oct 23, 2025 | +10.9% | +0.6% | 1.96 / 1.71 (+14.6%) |
| Jul 24, 2025 | before the open | Jul 23, 2025 → Jul 24, 2025 | +22.8% | 0% | 1.84 / 1.54 (+19.7%) |
| Apr 24, 2025 | before the open | Apr 23, 2025 → Apr 24, 2025 | −3.5% | +2.1% | |
| Feb 13, 2025 | before the open | Feb 12, 2025 → Feb 13, 2025 | −38.2% | +1.1% | |
| Oct 24, 2024 | before the open | Oct 23, 2024 → Oct 24, 2024 | +15.4% | +0.2% |
WST window: when it reported before the open or during market hours, from the previous close to that day's. Split-adjusted closes and EPS with its estimate, from Yahoo Finance. It already happened: it does not anticipate the next announcement.
Where each number comes from
From the 8-K with item 2.02 ("Results of Operations and Financial Condition") that West Pharmaceutical Services filed on EDGAR, the SEC's public database; only those with their 10-Q or 10-K behind them count, so other 8-Ks with the same item (production figures, monthly sales) stay out. The time is converted to New York time using this specific company's stamp convention (its EDGAR stamp arrives in UTC), and it is not assumed: it is derived from the hours in which EDGAR accepts filings. In 1 of this company's 65 quarters the date comes from the EDGAR acceptance day rather than the 8-K cover box, and it is flagged with an asterisk in the table.
What this data does not know
- The exact time of the press release: the 8-K reaches EDGAR minutes or hours later, so West Pharmaceutical Services's median 07:42 is an upper bound. The session says which one the news landed in, not what minute it was said.
- Nothing before Aug 3, 2010: it is West Pharmaceutical Services's oldest quarter with announcement and report paired in the file.
- What will happen. The page's only future date, Oct 29, 2026, was announced by West Pharmaceutical Services on the Nasdaq calendar and can be moved. West Pharmaceutical Services reporting before the open 14 quarters in a row does not say the next one will be the same.
- West Pharmaceutical Services's identity is its SEC CIK (0000105770), not its symbol: symbols get recycled and renamed.
When other Healthcare companies report earnings
- MRNA
- LLY
- INCY
- CAH
- ELV
- SOLV
- BMY
- DXCM
- CVS
- HSIC
- VTRS
- JNJ
- DVA
- UHS
- CI
- BIIB
- VRTX
- REGN
- CNC
- MRK
- EW
- HUM
- MCK
- COR
- AMGN
- WAT
- TECH
- ABBV
- IDXX
- DGX
- RVTY
- MTD
- A
- ZBH
- ISRG
- TMO
- ALGN
- HCA
- UNH
- COO
- BDX
- VEEV
- MDT
- DHR
- PFE
- LH
- RMD
- IQV
- GEHC
- STE
- PODD
- BSX
- SYK
- BAX
- CRL
- ZTS
- ABT
- GILD
- PHM
- KVUE
More on West Pharmaceutical Services
West Pharmaceutical Services is in the Healthcare sector. On the model's multifactor score of Oct 21, 2026 it ranks 194 of 464, and 25 of the 55 companies in its sector that score. It is a quantitative model ranking, not a recommendation.
West Pharmaceutical Services (WST) analysis page →
All ~500 S&P 500 companies, sorted by when they report →
Guide: 10-K, 10-Q and 8-K · all guides
What is behind these dates
The concepts on this page, explained from scratch in the Academy. Free, no account.
- Guessing next quarter's earnings gives no edgeWhy knowing a quarter's earnings in advance is not enough to make money: what moves the price is the gap against what was expected.
- Supply, demand and price: why it rises and falls constantlyWhat happens to the price on announcement day, and why excellent results can leave the stock falling.
- The three financial statements of a companyWhat is inside the 10-Q and the 10-K whose lag behind the announcement this page measures.
- Point-in-time data and look-ahead biasWhy the date a figure became public matters as much as the figure, which is exactly the distinction behind the two date columns above.
Source: EDGAR, the SEC's public database (forms 8-K, 10-Q and 10-K). Data through Jul 23, 2026. This is a list of public facts and of calculations made on them, not financial advice or a recommendation to buy or sell.